BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27666520)

  • 1. Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis.
    Bai Y; Zhou HM; Zhang L; Dong Y; Zeng Q; Shou W; Zhang ZY
    Sci Rep; 2016 Sep; 6():34211. PubMed ID: 27666520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.
    Dong Y; Zhang L; Bai Y; Zhou HM; Campbell AM; Chen H; Yong W; Zhang W; Zeng Q; Shou W; Zhang ZY
    J Biol Chem; 2014 Feb; 289(6):3799-810. PubMed ID: 24371141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and activating Akt protein.
    Dong Y; Zhang L; Zhang S; Bai Y; Chen H; Sun X; Yong W; Li W; Colvin SC; Rhodes SJ; Shou W; Zhang ZY
    J Biol Chem; 2012 Sep; 287(38):32172-9. PubMed ID: 22791713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of PRL2 phosphatase-mediated PTEN degradation and tumorigenesis.
    Li Q; Bai Y; Lyle LT; Yu G; Amarasinghe O; Nguele Meke F; Carlock C; Zhang ZY
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20538-20548. PubMed ID: 32788364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic regulatory locus 2 exhibits unequal genetic redundancy with its homolog PRL1.
    Weihmann T; Palma K; Nitta Y; Li X
    Plant Cell Physiol; 2012 Sep; 53(9):1617-26. PubMed ID: 22813545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
    Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
    Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.
    Kobayashi M; Chen S; Gao R; Bai Y; Zhang ZY; Liu Y
    Cell Cycle; 2014; 13(18):2827-35. PubMed ID: 25486470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia.
    Carlock C; Bai Y; Paige-Hood A; Li Q; Nguele Meke F; Zhang ZY
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37665633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration.
    Sun JP; Luo Y; Yu X; Wang WQ; Zhou B; Liang F; Zhang ZY
    J Biol Chem; 2007 Sep; 282(39):29043-29051. PubMed ID: 17656357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting PRL phosphatases in hematological malignancies.
    Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
    Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prolactin in pregnancy hypertension.
    Marlettini MG; Cassani A; Morselli Labate AM; Rusticali AG; Crippa S; Trabatti M; Miniero R; Plate L; Orlandi C
    Clin Exp Hypertens A; 1987; 9(5-6):1099-119. PubMed ID: 3304730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL2 links magnesium flux and sex-dependent circadian metabolic rhythms.
    Uetani N; Hardy S; Gravel SP; Kiessling S; Pietrobon A; Wong NN; Chénard V; Cermakian N; St-Pierre J; Tremblay ML
    JCI Insight; 2017 Jul; 2(13):. PubMed ID: 28679948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.
    Bai Y; Yu ZH; Liu S; Zhang L; Zhang RY; Zeng LF; Zhang S; Zhang ZY
    Cancer Res; 2016 Aug; 76(16):4805-15. PubMed ID: 27325652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL1 Promotes Glioblastoma Invasion and Tumorigenesis
    Qiu W; Cai X; Xu K; Song S; Xiao Z; Hou Y; Qi X; Liu F; Chen Y; Yang H; Chu L; Liu J
    Front Oncol; 2021; 11():795633. PubMed ID: 35111679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.
    Gehring K; Miki H
    Br J Cancer; 2021 Mar; 124(6):1035-1036. PubMed ID: 33268817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
    Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
    Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.
    Coultas L; Bouillet P; Loveland KL; Meachem S; Perlman H; Adams JM; Strasser A
    EMBO J; 2005 Nov; 24(22):3963-73. PubMed ID: 16270031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a leptin deficiency on testicular morphology, germ cell apoptosis, and expression levels of apoptosis-related genes in the mouse.
    Bhat GK; Sea TL; Olatinwo MO; Simorangkir D; Ford GD; Ford BD; Mann DR
    J Androl; 2006; 27(2):302-10. PubMed ID: 16304204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.